CapSure Showed the Association of Statin and Nonsteroidal Anti-inflammatory Drug use with Prostate Cancer All Cause Survival
In the prostate cancer world we often discuss treatment options, some approved by the FDA and some not approved. Among the treatment options bantered about are statins (3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor) and nonsteroidal anti-inflammatory [...]
Now an Early Access Site for Alpharedin Opens in New York
The Early Access Committee on which Malecare sits has been successful in adding an additional site in Long Island, New York to the Early Access Trial of Radium-233 Chloride (Alpharedin) for men with advanced prostate [...]
Xtandi Today & Tomorrow
Medivation, the pharmaceutical company that owns Xtandi (formerly known as MDV-3100), the new androgen receptor antagonist to treat castrate resistant advanced prostate cancer has a number of active clinical trials, despite the fact that it [...]
Radium-223 (Alpharedin) Improves Survival in Men with Metastatic Prostate Cancer
At the October 28 meeting of the American Society for Radiation the final data from the ALSYMPCA trial were presented. The trial evaluated radium-223 (Alpharedin) in men with castrate-resistant prostate cancer that had spread to [...]
So, Where Is Your Evidence – Is Our Propensity to Believe the Folk Law Wasting our Time & Money
Having hot flashes because of hormone deprivation therapy (ADT)? All of us dealing with advanced prostate cancer will be on ADT, it is the usual first line of therapy and it will continue until we [...]
How Much Does that Drug Cost? You Have to be Kidding!
How much money is a drug worth and how much money should we be willing to spend for it have been questions that have been increasingly asked by economists, doctors and cancer survivors. Last month [...]